Revisión
Uso terapéutico de las vesículas extracelulares en insuficiencia renal aguda y crónica
Therapeutic application of extracellular vesicles in acute and chronic renal injury
Jordi Roviraa,b, Fritz Diekmanna,b,c,
, Josep M. Campistola,b,c, María José Ramírez-Bajoa
Autor para correspondencia
a Laboratori Experimental de Nefrologia i Trasplantament (LENIT), Centre de Recerca Biomèdica CELLEX, Fundació Clínic per la Recerca Biomèdica (FCRB), Barcelona, España
b Laboratori Experimental de Nefrologia i Trasplantament (LENIT), Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, España
c Departamento de Nefrología y Trasplante Renal, Institut Clínic de Nefrologia i Urologia (ICNU), Hospital Clínic, Barcelona, España
Leído
24537
Vecesse ha leído el artículo
4262
Total PDF
20275
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 358 | 48 | 406 |
| 2025 5 | 655 | 57 | 712 |
| 2025 4 | 440 | 42 | 482 |
| 2025 3 | 459 | 78 | 537 |
| 2025 2 | 401 | 50 | 451 |
| 2025 1 | 363 | 53 | 416 |
| 2024 12 | 257 | 59 | 316 |
| 2024 11 | 285 | 67 | 352 |
| 2024 10 | 228 | 65 | 293 |
| 2024 9 | 202 | 46 | 248 |
| 2024 8 | 217 | 79 | 296 |
| 2024 7 | 190 | 42 | 232 |
| 2024 6 | 209 | 66 | 275 |
| 2024 5 | 215 | 49 | 264 |
| 2024 4 | 184 | 36 | 220 |
| 2024 3 | 194 | 54 | 248 |
| 2024 2 | 191 | 35 | 226 |
| 2024 1 | 167 | 38 | 205 |
| 2023 12 | 141 | 32 | 173 |
| 2023 11 | 253 | 55 | 308 |
| 2023 10 | 203 | 47 | 250 |
| 2023 9 | 191 | 30 | 221 |
| 2023 8 | 227 | 33 | 260 |
| 2023 7 | 260 | 48 | 308 |
| 2023 6 | 171 | 34 | 205 |
| 2023 5 | 154 | 33 | 187 |
| 2023 4 | 141 | 40 | 181 |
| 2023 3 | 227 | 44 | 271 |
| 2023 2 | 154 | 34 | 188 |
| 2022 1 | 248 | 52 | 300 |
| 2022 12 | 201 | 31 | 232 |
| 2022 11 | 176 | 57 | 233 |
| 2022 10 | 203 | 54 | 257 |
| 2022 9 | 134 | 39 | 173 |
| 2022 8 | 150 | 48 | 198 |
| 2022 7 | 155 | 61 | 216 |
| 2022 6 | 141 | 43 | 184 |
| 2022 5 | 195 | 58 | 253 |
| 2022 4 | 285 | 77 | 362 |
| 2022 3 | 266 | 79 | 345 |
| 2022 2 | 247 | 67 | 314 |
| 2021 1 | 231 | 62 | 293 |
| 2021 12 | 188 | 53 | 241 |
| 2021 11 | 191 | 51 | 242 |
| 2021 10 | 248 | 61 | 309 |
| 2021 9 | 281 | 53 | 334 |
| 2021 8 | 191 | 63 | 254 |
| 2021 7 | 119 | 59 | 178 |
| 2021 6 | 99 | 51 | 150 |
| 2021 5 | 133 | 68 | 201 |
| 2021 4 | 207 | 118 | 325 |
| 2021 3 | 112 | 52 | 164 |
| 2021 2 | 142 | 66 | 208 |
| 2020 1 | 97 | 39 | 136 |
| 2020 12 | 90 | 41 | 131 |
| 2020 11 | 116 | 37 | 153 |
| 2020 10 | 136 | 43 | 179 |
| 2020 9 | 154 | 37 | 191 |
| 2020 8 | 136 | 25 | 161 |
| 2020 7 | 158 | 41 | 199 |
| 2020 6 | 143 | 38 | 181 |
| 2020 5 | 175 | 30 | 205 |
| 2020 4 | 188 | 46 | 234 |
| 2020 3 | 130 | 28 | 158 |
| 2020 2 | 203 | 37 | 240 |
| 2020 1 | 256 | 34 | 290 |
| 2019 12 | 144 | 22 | 166 |
| 2019 11 | 181 | 32 | 213 |
| 2019 10 | 242 | 46 | 288 |
| 2019 9 | 160 | 33 | 193 |
| 2019 8 | 103 | 32 | 135 |
| 2019 7 | 106 | 31 | 137 |
| 2019 6 | 103 | 23 | 126 |
| 2019 5 | 123 | 35 | 158 |
| 2019 4 | 154 | 50 | 204 |
| 2019 3 | 89 | 46 | 135 |
| 2019 2 | 88 | 37 | 125 |
| 2019 1 | 66 | 29 | 95 |
| 2018 12 | 275 | 69 | 344 |
| 2018 11 | 492 | 25 | 517 |
| 2018 10 | 216 | 15 | 231 |
| 2018 9 | 177 | 32 | 209 |
| 2018 8 | 120 | 17 | 137 |
| 2018 7 | 99 | 17 | 116 |
| 2018 6 | 125 | 23 | 148 |
| 2018 5 | 108 | 12 | 120 |
| 2018 4 | 121 | 14 | 135 |
| 2018 3 | 116 | 21 | 137 |
| 2018 2 | 108 | 7 | 115 |
| 2018 1 | 119 | 8 | 127 |
| 2017 12 | 125 | 18 | 143 |
| 2017 11 | 176 | 16 | 192 |
| 2017 10 | 101 | 12 | 113 |
| 2017 9 | 148 | 15 | 163 |
| 2017 8 | 185 | 37 | 222 |
| 2017 7 | 166 | 28 | 194 |
| 2017 6 | 226 | 20 | 246 |
| 2017 5 | 338 | 23 | 361 |
| 2017 4 | 262 | 16 | 278 |
| 2017 3 | 132 | 19 | 151 |
| 2017 2 | 101 | 9 | 110 |
| 2016 1 | 63 | 9 | 72 |
| 2016 12 | 76 | 9 | 85 |
| 2016 11 | 129 | 14 | 143 |
| 2016 10 | 149 | 13 | 162 |
| 2016 9 | 149 | 20 | 169 |
| 2016 8 | 172 | 10 | 182 |
| 2016 7 | 80 | 5 | 85 |
Mostrar todo
